Clinical outcomes 
Three patients died during the study. One patient died due to graft failure and another due to IPA, in the third case of death fungi was not detected in the last bronchoalveolar lavage available.
Two patients affected by CF who suffered fungal lung colonization did not have exacerbations requiring antifungal treatment or hospitalization during the time of the study. One patient receiving nebulized voriconazole as prophylaxis after LT had an adequate clinical evolution during the follow-up. There were three cases of microbiological response and voriconazole resistance was developed in one case.